共 31 条
Can We Improve Outcomes in Patients With Previous Coronary Artery Bypass Surgery Admitted for Acute Coronary Syndrome?
被引:10
作者:
Teixeira, Rogerio
[1
]
Lourenco, Carolina
Antonio, Natalia
Jorge, Elisabete
Baptista, Rui
Saraiva, Fatima
Mendes, Paulo
Monteiro, Silvia
Goncalves, Francisco
Monteiro, Pedro
Freitas, Mario
Providencia, Luis A.
机构:
[1] Coimbra Univ Hosp, Dept Cardiol, Unidad Cuidados Coronarios, P-3000050 Coimbra, Portugal
来源:
REVISTA ESPANOLA DE CARDIOLOGIA
|
2010年
/
63卷
/
05期
关键词:
Coronary artery bypass graft;
Acute coronary syndrome;
Prognosis;
ACUTE MYOCARDIAL-INFARCTION;
SAPHENOUS-VEIN GRAFTS;
DRUG-ELUTING STENTS;
UNSTABLE ANGINA;
TERM;
ANGIOPLASTY;
PREDICTORS;
IMMEDIATE;
SURVIVAL;
LESIONS;
D O I:
10.1016/S0300-8932(10)70117-2
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Introduction and objectives. Prognosis and in-hospital management of patients with acute coronary syndrome (ACS) and a history of coronary artery bypass graft (CABG) surgery are still debated. The objective of this study was to characterize ACS patients with a CABG and to compare their in-hospital and postdischarge outcomes with those of patients without a CABG. Methods. This ongoing prospective observational study included 1,495 consecutive patients admitted for ACS to a coronary care unit and followed up for a mean of 19 months. There were two groups: group A (n=73), with CABGs; and group B (n=1,223), without CABGs. Results. Group A patients were more often male (86.3% versus 69.1%; P=.002), and more frequently had a history of diabetes, myocardial infarction and heart failure. Group B patients more frequently had ST-elevation myocardial infarction, and had a higher median ejection fraction (53% [interquartile range, 47%-60%] vs. 50% [42%-55%]; P<.01) and peak troponin-I concentration. There was no difference in the use of invasive techniques. Regarding medication, Group B patients were more likely to receive dual antiplatelet therapy at discharge. No significant difference was observed in in-hospital mortality (9.5% versus 5.9%; P=.2) or mortality at 1 month, 6 months or 1 year (9.8% versus 9.1%; log-rank test, P=.87) and the cumulative major adverse cardiac event rate was equally low in both groups. The presence of a CABG was associated with more readmissions for unstable angina (11.3% vs. 3.1%; P<.01). Conclusions. In our ACS patients, the presence of a CABG had no significant influence on short- or medium-term outcomes, such as all-cause mortality and adverse cardiac events.
引用
收藏
页码:554 / 563
页数:10
相关论文